{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T14:00:06Z","timestamp":1770300006878,"version":"3.49.0"},"reference-count":70,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,1]]},"abstract":"<jats:p>Persistence of a left-to-right shunt caused by a patent ductus arteriosus (PDA) leads to significant sequelae in extremely premature infants as a result of pulmonary overcirculation and systemic steal. Although timing and duration of treatment for a persistent clinically significant PDA differ among institutions, standard pharmacologic interventions are the nonsteroidal anti-inflammatory drugs indomethacin and ibuprofen. Acetaminophen has emerged as an alternative to indomethacin and ibuprofen with less significant adverse effects, but there is no consensus regarding its use. This review summarizes the most recent evidence for the use of acetaminophen in PDA treatment.<\/jats:p>","DOI":"10.1542\/neo.22-5-e320","type":"journal-article","created":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T09:25:29Z","timestamp":1619774729000},"page":"e320-e331","source":"Crossref","is-referenced-by-count":5,"title":["Acetaminophen Therapy for Persistent Patent Ductus Arteriosus"],"prefix":"10.1542","volume":"22","author":[{"given":"Maika","family":"Manalastas","sequence":"first","affiliation":[{"name":"Division of Neonatology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima","family":"Zaheer","sequence":"additional","affiliation":[{"name":"Division of Neonatology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Nicoski","sequence":"additional","affiliation":[{"name":"Division of Neonatology, and"},{"name":"Department of Pharmacy, Loyola University Medical Center, Maywood, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc G.","family":"Weiss","sequence":"additional","affiliation":[{"name":"Division of Neonatology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachin","family":"Amin","sequence":"additional","affiliation":[{"name":"Division of Neonatology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2021,5,1]]},"reference":[{"key":"2021121008051714700_B1","volume-title":"Fanaroff and Martin\u2019s Neonatal-Perinatal Medicine E-Book: Diseases of the Fetus and Infant","author":"Martin","year":"2020"},{"issue":"1","key":"2021121008051714700_B2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41390-019-0387-7","article-title":"Understanding the pathobiology in patent ductus arteriosus in prematurity-beyond prostaglandins and oxygen","volume":"86","author":"Hundscheid","year":"2019","journal-title":"Pediatr Res"},{"issue":"10","key":"2021121008051714700_B3","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1056\/NEJM200009073431009","article-title":"Ibuprofen and patent ductus arteriosus","volume":"343","author":"Clyman","year":"2000","journal-title":"N Engl J Med"},{"issue":"11","key":"2021121008051714700_B4","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/s41372-019-0506-7","article-title":"Patent ductus arteriosus in preterm infants: is early transcatheter closure a paradigm shift?","volume":"39","author":"Vali","year":"2019","journal-title":"J Perinatol"},{"issue":"1","key":"2021121008051714700_B5","doi-asserted-by":"crossref","first-page":"e20153730","DOI":"10.1542\/peds.2015-3730","article-title":"Patent ductus arteriosus in preterm infants","volume":"137","author":"Benitz","year":"2016","journal-title":"Pediatrics"},{"issue":"3","key":"2021121008051714700_B6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/ANC.0000000000000590","article-title":"Understanding the pathophysiology, implications, and treatment options of patent ductus arteriosus in the neonatal population","volume":"19","author":"Conrad","year":"2019","journal-title":"Adv Neonatal Care"},{"issue":"suppl 1","key":"2021121008051714700_B7","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1038\/sj.jp.7211465","article-title":"Patent ductus arteriosus: pathophysiology and management","volume":"26","author":"Hermes-DeSantis","year":"2006","journal-title":"J Perinatol"},{"issue":"1","key":"2021121008051714700_B8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/chd.12701","article-title":"Effect of patent ductus arteriosus on the heart in preterm infants","volume":"14","author":"Philip","year":"2019","journal-title":"Congenit Heart Dis"},{"issue":"8","key":"2021121008051714700_B9","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1001\/jamapediatrics.2020.1447","article-title":"Effect of nonintervention vs oral ibuprofen in patent ductus arteriosus in preterm infants: a randomized clinical trial","volume":"174","author":"Sung","year":"2020","journal-title":"JAMA Pediatr"},{"key":"2021121008051714700_B10","first-page":"CD010061","article-title":"Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants","volume":"1","author":"Ohlsson","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"2021121008051714700_B11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/jp.2010.3","article-title":"Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis?","volume":"30","author":"Benitz","year":"2010","journal-title":"J Perinatol"},{"issue":"7","key":"2021121008051714700_B12","doi-asserted-by":"crossref","first-page":"e394","DOI":"10.1542\/neo.19-7-e394","article-title":"Diagnosis and management of patent ductus arteriosus","volume":"19","author":"Gillam-Krakauer","year":"2018","journal-title":"NeoReviews"},{"key":"2021121008051714700_B13","first-page":"CD003481","article-title":"Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants","volume":"2","author":"Ohlsson","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"2021121008051714700_B14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00431-016-2830-7","article-title":"Comparative study of the efficacy and safety of paracetamol, ibuprofen, and indomethacin in closure of patent ductus arteriosus in preterm neonates","volume":"176","author":"El-Mashad","year":"2017","journal-title":"Eur J Pediatr"},{"issue":"10","key":"2021121008051714700_B15","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/j.1460-9592.2008.02764.x","article-title":"Paracetamol (acetaminophen): mechanisms of action","volume":"18","author":"Anderson","year":"2008","journal-title":"Paediatr Anaesth"},{"issue":"1","key":"2021121008051714700_B16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.clpt.2005.09.009","article-title":"New insights into the mechanism of action of acetaminophen: its clinical pharmacologic characteristics reflect its inhibition of the two prostaglandin H2 synthases","volume":"79","author":"Aronoff","year":"2006","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"2021121008051714700_B17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10787-013-0172-x","article-title":"The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings","volume":"21","author":"Graham","year":"2013","journal-title":"Inflammopharmacology"},{"issue":"4","key":"2021121008051714700_B18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1053\/j.semperi.2018.05.007","article-title":"Evidence-based use of acetaminophen for hemodynamically significant ductus arteriosus in preterm infants","volume":"42","author":"Jasani","year":"2018","journal-title":"Semin Perinatol"},{"key":"2021121008051714700_B19","unstructured":"Mallinckrodt Pharmaceuticals. Ofirmev (acetaminophen) [prescribing information]. Available at: https:\/\/www.mallinckrodt.com\/globalassets\/documents\/products\/brands\/ofirmev-pi.pdf. Accessed February 1, 2021"},{"issue":"3","key":"2021121008051714700_B20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00228-003-0608-0","article-title":"Paracetamol and metabolite pharmacokinetics in infants","volume":"59","author":"van der Marel","year":"2003","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"2021121008051714700_B21","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1097\/00000542-200206000-00012","article-title":"Acetaminophen developmental pharmacokinetics in premature neonates and infants: a pooled population analysis","volume":"96","author":"Anderson","year":"2002","journal-title":"Anesthesiology"},{"issue":"1","key":"2021121008051714700_B22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s40262-015-0301-3","article-title":"Population pharmacokinetics of intravenous paracetamol (acetaminophen) in preterm and term neonates: model development and external evaluation","volume":"55","author":"Cook","year":"2016","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"2021121008051714700_B23","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/bja\/aen208","article-title":"I.V. acetaminophen pharmacokinetics in neonates after multiple doses","volume":"101","author":"Palmer","year":"2008","journal-title":"Br J Anaesth"},{"key":"2021121008051714700_B24","unstructured":"Truven Health Analytics. Acetaminophen. https:\/\/www.micromedexsolutions.com\/micromedex2\/librarian\/PFActionId\/evidencexpert.GetNeofaxDrugMonograph?navitem=neofaxDrugMonographDocRetrieval&drugName=Acetaminophen&tabSelected=neonatal#. Accessed August 16, 2020."},{"issue":"1","key":"2021121008051714700_B25","doi-asserted-by":"crossref","first-page":"F59","DOI":"10.1136\/fn.80.1.F59","article-title":"Pharmacokinetics and metabolism of rectally administered paracetamol in preterm neonates","volume":"80","author":"van Lingen","year":"1999","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"5","key":"2021121008051714700_B26","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41372-019-0347-4","article-title":"Comparative effectiveness of drugs used to constrict the patent ductus arteriosus: a secondary analysis of the PDA-TOLERATE trial (NCT01958320)","volume":"39","author":"Liebowitz","year":"2019","journal-title":"J Perinatol"},{"issue":"1","key":"2021121008051714700_B27","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1034\/j.1399-6576.2001.450104.x","article-title":"Treatment with paracetamol in infants","volume":"45","author":"Arana","year":"2001","journal-title":"Acta Anaesthesiol Scand"},{"issue":"16","key":"2021121008051714700_B28","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.3109\/14767058.2013.871630","article-title":"Paracetamol effectiveness, safety and blood level monitoring during patent ductus arteriosus closure: a case series","volume":"27","author":"Kessel","year":"2014","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"2","key":"2021121008051714700_B29","first-page":"86","article-title":"Prophylactic teatment with oral paracetamol for patent ductus arteriosus in preterm infants: a randomized clinical trial","volume":"73","author":"Asbagh","year":"2015","journal-title":"Tehran Univ Med J"},{"key":"2021121008051714700_B30","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4103\/jrms.JRMS_197_19","article-title":"Comparison of oral acetaminophen with oral ibuprofen on closure of symptomatic patent ductus arteriosus in preterm neonates","volume":"24","author":"Ghaderian","year":"2019","journal-title":"J Res Med Sci"},{"issue":"7","key":"2021121008051714700_B31","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s13312-015-0677-z","article-title":"Enteral paracetamol or intravenous indomethacin for closure of patent ductus arteriosus in preterm neonates: a randomized controlled trial","volume":"52","author":"Dash","year":"2015","journal-title":"Indian Pediatr"},{"issue":"4","key":"2021121008051714700_B32","doi-asserted-by":"crossref","first-page":"e3975","DOI":"10.5812\/ijp.3975","article-title":"Comparison of Oral Acetaminophen Versus Ibuprofen in Premature Infants With Patent Ductus Arteriosus","volume":"26","author":"Bagheri","year":"2016","journal-title":"Iran J Pediatr"},{"issue":"11","key":"2021121008051714700_B33","doi-asserted-by":"crossref","first-page":"e77888","DOI":"10.1371\/journal.pone.0077888","article-title":"Comparison of oral paracetamol versus ibuprofen in premature infants with patent ductus arteriosus: a randomized controlled trial","volume":"8","author":"Dang","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"2021121008051714700_B34","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.3892\/etm.2016.3676","article-title":"Oral paracetamol vs. oral ibuprofen in the treatment of symptomatic patent ductus arteriosus in premature infants: a randomized controlled trial","volume":"12","author":"Yang","year":"2016","journal-title":"Exp Ther Med"},{"key":"2021121008051714700_B35","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jpeds.2020.01.058","article-title":"Oral paracetamol vs oral ibuprofen in patent ductus arteriosus: a randomized, controlled, noninferiority trial","volume":"222","author":"Kumar","year":"2020","journal-title":"J Pediatr"},{"issue":"4","key":"2021121008051714700_B36","doi-asserted-by":"crossref","first-page":"224","DOI":"10.4103\/jcn.JCN_47_18","article-title":"Comparison of the effect of oral acetaminophen and ibuprofenon patent ductus arteriosus closure in premature infants referred to hajarhospital in Shahrekord in 2016\u20132017","volume":"7","author":"Asadpour","year":"2018","journal-title":"J Clin Neonatol"},{"issue":"5","key":"2021121008051714700_B37","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.15419\/bmrat.v5i02.418","article-title":"Closure of patent ductus arteriosus with oral acetaminophen in preterm neonates: a randomized trial","author":"Babaei","year":"2018","journal-title":"Biomed Res Ther"},{"issue":"21","key":"2021121008051714700_B38","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1080\/14767058.2018.1470235","article-title":"Efficacy and safety of oral paracetamol versus oral ibuprofen for closure of patent ductus arteriosus in preterm infants: a randomized controlled trial","volume":"32","author":"El-Farrash","year":"2019","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"3","key":"2021121008051714700_B39","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1002\/hsr2.183","article-title":"Intravenous acetaminophen vs intravenous ibuprofen to close a patent ductus arteriosus closure: a pilot randomized controlled trial","volume":"3","author":"Tauber","year":"2020","journal-title":"Health Sci Rep"},{"issue":"2","key":"2021121008051714700_B40","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4103\/apc.APC_115_19","article-title":"Comparison of the efficacy and safety of indomethacin, ibuprofen, and paracetamol in the closure of patent ductus arteriosus in preterm neonates - A randomized controlled trial","volume":"13","author":"Meena","year":"2020","journal-title":"Ann Pediatr Cardiol"},{"key":"2021121008051714700_B41","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jpeds.2016.04.066","article-title":"Paracetamol accelerates closure of the ductus arteriosus after premature birth: a randomized trial","volume":"177","author":"H\u00e4rkin","year":"2016","journal-title":"J Pediatr"},{"issue":"2","key":"2021121008051714700_B42","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1177\/0300060517722698","article-title":"Oral paracetamol versus oral ibuprofen for treatment of patent ductus arteriosus","volume":"46","author":"Al-Lawama","year":"2018","journal-title":"J Int Med Res"},{"issue":"1","key":"2021121008051714700_B43","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/14767058.2014.989829","article-title":"Oral versus intravenous paracetamol: which is better in closure of patent ductus arteriosus in very low birth weight infants?","volume":"29","author":"Sancak","year":"2016","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"6","key":"2021121008051714700_B44","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/adc.2010.204552","article-title":"The pharmacokinetics of intravenous paracetamol in neonates: size matters most","volume":"96","author":"Allegaert","year":"2011","journal-title":"Arch Dis Child"},{"issue":"6","key":"2021121008051714700_B45","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/jcph.259","article-title":"Population pharmacokinetics of paracetamol across the human age-range from (pre)term neonates, infants, children to adults","volume":"54","author":"Wang","year":"2014","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"2021121008051714700_B46","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4103\/apc.APC_42_18","article-title":"Acetaminophen in low doses for closure of the ductus arteriosus of the premature","volume":"12","author":"Guimar\u00e3es","year":"2019","journal-title":"Ann Pediatr Cardiol"},{"issue":"9","key":"2021121008051714700_B47","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1080\/14767058.2018.1525354","article-title":"Comparison of efficacy of oral paracetamol versus ibuprofen for PDA closure in preterms - a prospective randomized clinical trial","volume":"33","author":"Balachander","year":"2020","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2021121008051714700_B48","article-title":"Intravenous paracetamol in comparison with ibuprofen for the treatment of patent ductus arteriosus in preterm infants: a randomized controlled trial [published online ahead of print September 4, 2020]","author":"Dani","journal-title":"Eur J Pediatr"},{"issue":"3","key":"2021121008051714700_B49","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jpeds.2013.11.008","article-title":"Oral paracetamol versus oral ibuprofen in the management of patent ductus arteriosus in preterm infants: a randomized controlled trial","volume":"164","author":"Oncel","year":"2014","journal-title":"J Pediatr"},{"key":"2021121008051714700_B50","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3389\/fped.2019.00568","article-title":"Efficacy and safety of paracetamol for patent ductus arteriosus closure in preterm infants: an updated systematic review and meta-analysis","volume":"7","author":"Xiao","year":"2020","journal-title":"Front Pediatr"},{"issue":"12","key":"2021121008051714700_B51","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1001\/jama.2018.1896","article-title":"Association of placebo, indomethacin, ibuprofen, and acetaminophen with closure of hemodynamically significant patent ductus arteriosus in preterm infants: a systematic review and meta-analysis","volume":"319","author":"Mitra","year":"2018","journal-title":"JAMA"},{"issue":"6","key":"2021121008051714700_B52","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1017\/S1047951114001577","article-title":"Intravenous paracetamol with a lower dose is also effective for the treatment of patent ductus arteriosus in pre-term infants","volume":"25","author":"Tekg\u00fcnd\u00fcz","year":"2015","journal-title":"Cardiol Young"},{"issue":"3","key":"2021121008051714700_B53","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000352068","article-title":"Is paracetamol a useful treatment for ibuprofen-resistant patent ductus arteriosus? Concerning the article by M.Y. Oncel et al: intravenous paracetamol treatment in the management of patent ductus arteriosus in extremely low birth weight infants [Neonatology 2013;103:166-169]","volume":"104","author":"Alan","year":"2013","journal-title":"Neonatology"},{"issue":"3","key":"2021121008051714700_B54","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/sj.jp.7211439","article-title":"New insights into spontaneous intestinal perforation using a national data set: (2) two populations of patients with perforations","volume":"26","author":"Attridge","year":"2006","journal-title":"J Perinatol"},{"issue":"5","key":"2021121008051714700_B55","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1203\/PDR.0b013e318155ac3b","article-title":"Hydrocortisone and indomethacin negatively modulate EGF-R signaling in human fetal intestine","volume":"62","author":"Kajanne","year":"2007","journal-title":"Pediatr Res"},{"issue":"7","key":"2021121008051714700_B56","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/jp.2010.199","article-title":"Gastrointestinal complications associated with ibuprofen therapy for patent ductus arteriosus","volume":"31","author":"Rao","year":"2011","journal-title":"J Perinatol"},{"issue":"9","key":"2021121008051714700_B57","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s12098-020-03445-2","article-title":"Paracetamol for patent ductus arteriosus closure: high osmolality of enteral form and spontaneous intestinal perforation","volume":"87","author":"Tuteja","year":"2020","journal-title":"Ind J Pediatr"},{"issue":"12","key":"2021121008051714700_B58","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.3109\/14767058.2013.854327","article-title":"Early paracetamol treatment associated with lowered risk of persistent ductus arteriosus in very preterm infants","volume":"27","author":"Aikio","year":"2014","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"6","key":"2021121008051714700_B59","first-page":"461","article-title":"Acetaminophen for patent ductus arteriosus in extremely low-birth-weight neonates","volume":"22","author":"Luecke","year":"2017","journal-title":"J Pediatr Pharmacol Ther"},{"key":"2021121008051714700_B60","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.eurpsy.2017.10.007","article-title":"Prenatal exposure to acetaminophen and children's language development at 30 months","volume":"51","author":"Bornehag","year":"2018","journal-title":"Eur Psychiatry"},{"key":"2021121008051714700_B61","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.yhbeh.2018.01.003","article-title":"Prenatal paracetamol exposure and child neurodevelopment: a review","volume":"101","author":"Bauer","year":"2018","journal-title":"Horm Behav"},{"key":"2021121008051714700_B62","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jpeds.2018.02.046","article-title":"Acetaminophen in the neonatal intensive care unit: shotgun approach or silver bullet","volume":"198","author":"van den Anker","year":"2018","journal-title":"J Pediatr"},{"issue":"1","key":"2021121008051714700_B63","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/toxsci\/kft329","article-title":"Paracetamol (acetaminophen) administration during neonatal brain development affects cognitive function and alters its analgesic and anxiolytic response in adult male mice","volume":"138","author":"Viberg","year":"2014","journal-title":"Toxicol Sci"},{"issue":"12","key":"2021121008051714700_B64","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1055\/s-0037-1601564","article-title":"Neurodevelopmental outcomes of preterm infants treated with oral paracetamol versus ibuprofen for patent ductus arteriosus","volume":"34","author":"Oncel","year":"2017","journal-title":"Am J Perinatol"},{"issue":"3","key":"2021121008051714700_B65","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/apa.14614","article-title":"Follow-up study of the early, randomised paracetamol trial to preterm infants, found no adverse reactions at the two-years corrected age","volume":"108","author":"Juuj\u00e4rvi","year":"2019","journal-title":"Acta Paediatr"},{"issue":"1","key":"2021121008051714700_B66","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/toxsci\/kfq375","article-title":"Acetaminophen-NAPQI hepatotoxicity: a cell line model system genome-wide association study","volume":"120","author":"Moyer","year":"2011","journal-title":"Toxicol Sci"},{"key":"2021121008051714700_B67","unstructured":"UpToDate I. Acetaminophen. Pediatric and Neonatal Lexi-Drugs Online. Web site. https:\/\/www.uptodate.com\/contents\/acetaminophen-paracetamol-drug-information#F129302. Updated 2020. Accessed October 30, 2020"},{"key":"2021121008051714700_B68","unstructured":"UpToDate I. Indomethacin. Pediatric and Neonatal Lexi-Drugs Online Web site. https:\/\/www.uptodate.com\/contents\/indomethacin-drug-information#F182638. Updated 2020. Accessed October 30, 2020"},{"key":"2021121008051714700_B69","unstructured":"UpToDate I. Ibuprofen. Pediatric and Neonatal Lexi-Drugs Online. Web site. https:\/\/www.uptodate.com\/contents\/ibuprofen-drug-information#F181440. Updated 2020. Accessed October 30, 2020"},{"issue":"13","key":"2021121008051714700_B70","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1055\/s-0038-1653946","article-title":"adding paracetamol to ibuprofen for the treatment of patent ductus arteriosus in preterm infants: a double-blind, randomized, placebo-controlled pilot study","volume":"35","author":"Hochwald","year":"2018","journal-title":"Am J Perinatol"}],"container-title":["NeoReviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/neoreviews\/article-pdf\/22\/5\/e320\/1178274\/neoreviews_112020cmerev00178.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/neoreviews\/article-pdf\/22\/5\/e320\/1178274\/neoreviews_112020cmerev00178.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T19:53:54Z","timestamp":1639166034000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/neoreviews\/article\/22\/5\/e320\/180667\/Acetaminophen-Therapy-for-Persistent-Patent-Ductus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,1]]},"references-count":70,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,5,1]]},"published-print":{"date-parts":[[2021,5,1]]}},"URL":"https:\/\/doi.org\/10.1542\/neo.22-5-e320","relation":{},"ISSN":["1526-9906"],"issn-type":[{"value":"1526-9906","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,1]]}}}